COMMUNIQUÉ DE PRESSE publié le 10/05/2024 à 22:30, il y a 1 année 8 mois Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024 Integrated BioPharma, Inc. reports financial results for Q1 2024, showing stable revenue and net income compared to Q1 2023. The company aims to reduce reliance on key customers. Details and future outlook provided Financial Results Revenue Net Income Integrated BioPharma Inc. Customer Base
COMMUNIQUÉ DE PRESSE publié le 12/02/2024 à 22:25, il y a 1 année 11 mois Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023 Integrated BioPharma, Inc. reports financial results for the quarters and six-month periods ended December 31, 2023 and 2022, with revenue, operating losses, and net loss figures outlined Financial Results Revenue Integrated BioPharma Inc. Operating Losses Net Loss
COMMUNIQUÉ DE PRESSE publié le 09/11/2023 à 20:15, il y a 2 années 2 mois Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
COMMUNIQUÉ DE PRESSE publié le 15/09/2023 à 22:30, il y a 2 années 4 mois Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
COMMUNIQUÉ DE PRESSE publié le 11/05/2023 à 21:30, il y a 2 années 8 mois Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023
COMMUNIQUÉ DE PRESSE publié le 21/03/2023 à 20:15, il y a 2 années 10 mois Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President
COMMUNIQUÉ DE PRESSE publié le 10/02/2023 à 23:00, il y a 2 années 11 mois Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022
Publié le 05/02/2026 à 16:04, il y a 28 minutes MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Publié le 05/02/2026 à 16:02, il y a 30 minutes INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Publié le 05/02/2026 à 11:30, il y a 5 heures 2 minutes Déclaration nombre d'actions et droits de vote - 05.02.2026
Publié le 05/02/2026 à 11:30, il y a 5 heures 2 minutes Disclosure of shares outstanding and voting rights - 05.02.2026
Publié le 04/02/2026 à 18:04, il y a 22 heures 28 minutes Capital et droits de vote au 31 janvier 2026
Publié le 05/02/2026 à 15:45, il y a 47 minutes American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Publié le 05/02/2026 à 15:10, il y a 1 heure 22 minutes Electric Metals (USA) Limited Announces Change of Auditor
Publié le 05/02/2026 à 14:50, il y a 1 heure 42 minutes High Tide Resources Announces Non-Brokered Private Placements
Publié le 05/02/2026 à 14:30, il y a 2 heures 2 minutes Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Publié le 05/02/2026 à 14:30, il y a 2 heures 2 minutes Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Publié le 05/02/2026 à 16:20, il y a 12 minutes Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Publié le 05/02/2026 à 16:20, il y a 12 minutes Birla Carbon Launches New Continua™ SCM Production Line in Italy
Publié le 05/02/2026 à 15:56, il y a 36 minutes Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Kaufen
Publié le 05/02/2026 à 15:40, il y a 52 minutes BIKE24 exceeds revenue and earnings forecast for fiscal year 2025 – strong growth in the fourth quarter
Publié le 05/02/2026 à 15:34, il y a 58 minutes EQS-Adhoc: Bike24 Holding AG: Preliminary sales and earnings exceed the previous forecast range for the 2025 financial year